Our findings indicated that they may be potential prognostic markers for ccRCC, in addition to suggesting that PI3K/AKT/mTOR pathway signaling abnormalities may be involved in ccRCC tumorigenesis and progression. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.